Literature DB >> 28654055

Chromatin Immunoprecipitation (ChIP) in Mouse T-cell Lines.

Benedetto Daniele Giaimo1, Francesca Ferrante2, Tilman Borggrefe3.   

Abstract

Signaling pathways regulate gene expression programs via the modulation of the chromatin structure at different levels, such as by post-translational modifications (PTMs) of histone tails, the exchange of canonical histones with histone variants, and nucleosome eviction. Such regulation requires the binding of signal-sensitive transcription factors (TFs) that recruit chromatin-modifying enzymes at regulatory elements defined as enhancers. Understanding how signaling cascades regulate enhancer activity requires a comprehensive analysis of the binding of TFs, chromatin modifying enzymes, and the occupancy of specific histone marks and histone variants. Chromatin immunoprecipitation (ChIP) assays utilize highly specific antibodies to immunoprecipitate specific protein/DNA complexes. The subsequent analysis of the purified DNA allows for the identification the region occupied by the protein recognized by the antibody. This work describes a protocol to efficiently perform ChIP of histone proteins in a mature mouse T-cell line. The presented protocol allows for the performance of ChIP assays in a reasonable timeframe and with high reproducibility.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28654055      PMCID: PMC5608442          DOI: 10.3791/55907

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  22 in total

1.  High-resolution profiling of histone methylations in the human genome.

Authors:  Artem Barski; Suresh Cuddapah; Kairong Cui; Tae-Young Roh; Dustin E Schones; Zhibin Wang; Gang Wei; Iouri Chepelev; Keji Zhao
Journal:  Cell       Date:  2007-05-18       Impact factor: 41.582

2.  Identification and characterization of enhancers controlling the inflammatory gene expression program in macrophages.

Authors:  Serena Ghisletti; Iros Barozzi; Flore Mietton; Sara Polletti; Francesca De Santa; Elisa Venturini; Lorna Gregory; Lorne Lonie; Adeline Chew; Chia-Lin Wei; Jiannis Ragoussis; Gioacchino Natoli
Journal:  Immunity       Date:  2010-03-04       Impact factor: 31.745

3.  H3K4 tri-methylation provides an epigenetic signature of active enhancers.

Authors:  Aleksandra Pekowska; Touati Benoukraf; Joaquin Zacarias-Cabeza; Mohamed Belhocine; Frederic Koch; Hélène Holota; Jean Imbert; Jean-Christophe Andrau; Pierre Ferrier; Salvatore Spicuglia
Journal:  EMBO J       Date:  2011-08-16       Impact factor: 11.598

4.  High-throughput and quantitative assessment of enhancer activity in mammals by CapStarr-seq.

Authors:  Laurent Vanhille; Aurélien Griffon; Muhammad Ahmad Maqbool; Joaquin Zacarias-Cabeza; Lan T M Dao; Nicolas Fernandez; Benoit Ballester; Jean Christophe Andrau; Salvatore Spicuglia
Journal:  Nat Commun       Date:  2015-04-15       Impact factor: 14.919

5.  Latent enhancers activated by stimulation in differentiated cells.

Authors:  Renato Ostuni; Viviana Piccolo; Iros Barozzi; Sara Polletti; Alberto Termanini; Silvia Bonifacio; Alessia Curina; Elena Prosperini; Serena Ghisletti; Gioacchino Natoli
Journal:  Cell       Date:  2013-01-17       Impact factor: 41.582

6.  Site-specific methylation of Notch1 controls the amplitude and duration of the Notch1 response.

Authors:  Kerstin Hein; Gerhard Mittler; Wiebke Cizelsky; Michael Kühl; Francesca Ferrante; Robert Liefke; Ina M Berger; Steffen Just; J Eric Sträng; Hans A Kestler; Franz Oswald; Tilman Borggrefe
Journal:  Sci Signal       Date:  2015-03-24       Impact factor: 8.192

7.  CpG islands and GC content dictate nucleosome depletion in a transcription-independent manner at mammalian promoters.

Authors:  Romain Fenouil; Pierre Cauchy; Frederic Koch; Nicolas Descostes; Joaquin Zacarias Cabeza; Charlène Innocenti; Pierre Ferrier; Salvatore Spicuglia; Marta Gut; Ivo Gut; Jean-Christophe Andrau
Journal:  Genome Res       Date:  2012-10-25       Impact factor: 9.043

8.  An assessment of histone-modification antibody quality.

Authors:  Thea A Egelhofer; Aki Minoda; Sarit Klugman; Kyungjoon Lee; Paulina Kolasinska-Zwierz; Artyom A Alekseyenko; Ming-Sin Cheung; Daniel S Day; Sarah Gadel; Andrey A Gorchakov; Tingting Gu; Peter V Kharchenko; Samantha Kuan; Isabel Latorre; Daniela Linder-Basso; Ying Luu; Queminh Ngo; Marc Perry; Andreas Rechtsteiner; Nicole C Riddle; Yuri B Schwartz; Gregory A Shanower; Anne Vielle; Julie Ahringer; Sarah C R Elgin; Mitzi I Kuroda; Vincenzo Pirrotta; Bing Ren; Susan Strome; Peter J Park; Gary H Karpen; R David Hawkins; Jason D Lieb
Journal:  Nat Struct Mol Biol       Date:  2010-12-05       Impact factor: 15.369

9.  Dynamic chromatin regulation at Notch target genes.

Authors:  Benedetto Daniele Giaimo; Franz Oswald; Tilman Borggrefe
Journal:  Transcription       Date:  2016-12-27

10.  Dynamic recruitment of Ets1 to both nucleosome-occupied and -depleted enhancer regions mediates a transcriptional program switch during early T-cell differentiation.

Authors:  Pierre Cauchy; Muhammad A Maqbool; Joaquin Zacarias-Cabeza; Laurent Vanhille; Frederic Koch; Romain Fenouil; Marta Gut; Ivo Gut; Maria A Santana; Aurélien Griffon; Jean Imbert; Carolina Moraes-Cabé; Jean-Christophe Bories; Pierre Ferrier; Salvatore Spicuglia; Jean-Christophe Andrau
Journal:  Nucleic Acids Res       Date:  2015-12-15       Impact factor: 16.971

View more
  7 in total

1.  HDAC1 Is a Required Cofactor of CBFβ-SMMHC and a Potential Therapeutic Target in Inversion 16 Acute Myeloid Leukemia.

Authors:  Lisa E Richter; Yiqian Wang; Michelle E Becker; Rachel A Coburn; Jacob T Williams; Catalina Amador; R Katherine Hyde
Journal:  Mol Cancer Res       Date:  2019-02-27       Impact factor: 5.852

2.  IL-24 intrinsically regulates Th17 cell pathogenicity in mice.

Authors:  Christopher Sie; Ravi Kant; Christian Peter; Andreas Muschaweckh; Monika Pfaller; Lucy Nirschl; Helena Domínguez Moreno; Tereza Chadimová; Gildas Lepennetier; Tanja Kuhlmann; Rupert Öllinger; Thomas Engleitner; Roland Rad; Thomas Korn
Journal:  J Exp Med       Date:  2022-07-12       Impact factor: 17.579

3.  Histone variant H2A.Z deposition and acetylation directs the canonical Notch signaling response.

Authors:  Benedetto Daniele Giaimo; Francesca Ferrante; Diana M Vallejo; Kerstin Hein; Irene Gutierrez-Perez; Andrea Nist; Thorsten Stiewe; Gerhard Mittler; Susanne Herold; Tobias Zimmermann; Marek Bartkuhn; Peggy Schwarz; Franz Oswald; Maria Dominguez; Tilman Borggrefe
Journal:  Nucleic Acids Res       Date:  2018-09-19       Impact factor: 16.971

4.  Structural and Functional Studies of the RBPJ-SHARP Complex Reveal a Conserved Corepressor Binding Site.

Authors:  Zhenyu Yuan; Bradley D VanderWielen; Benedetto Daniele Giaimo; Leiling Pan; Courtney E Collins; Aleksandra Turkiewicz; Kerstin Hein; Franz Oswald; Tilman Borggrefe; Rhett A Kovall
Journal:  Cell Rep       Date:  2019-01-22       Impact factor: 9.423

5.  Loss of the transcription factor RBPJ induces disease-promoting properties in brain pericytes.

Authors:  Rodrigo Diéguez-Hurtado; Katsuhiro Kato; Benedetto Daniele Giaimo; Melina Nieminen-Kelhä; Hendrik Arf; Francesca Ferrante; Marek Bartkuhn; Tobias Zimmermann; M Gabriele Bixel; Hanna M Eilken; Susanne Adams; Tilman Borggrefe; Peter Vajkoczy; Ralf H Adams
Journal:  Nat Commun       Date:  2019-06-27       Impact factor: 14.919

6.  HDAC3 functions as a positive regulator in Notch signal transduction.

Authors:  Francesca Ferrante; Benedetto Daniele Giaimo; Marek Bartkuhn; Tobias Zimmermann; Viola Close; Daniel Mertens; Andrea Nist; Thorsten Stiewe; Johanna Meier-Soelch; Michael Kracht; Steffen Just; Patricia Klöble; Franz Oswald; Tilman Borggrefe
Journal:  Nucleic Acids Res       Date:  2020-04-17       Impact factor: 16.971

7.  Notch-dependent and -independent functions of transcription factor RBPJ.

Authors:  Tobias Friedrich; Francesca Ferrante; Léo Pioger; Andrea Nist; Thorsten Stiewe; Jean-Christophe Andrau; Marek Bartkuhn; Benedetto Daniele Giaimo; Tilman Borggrefe
Journal:  Nucleic Acids Res       Date:  2022-08-12       Impact factor: 19.160

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.